Healthcare Disparities
By Colleen Hall
While the panel acknowledged there is a long way to go in terms of encouraging diverse patient populations to participate in clinical trials, they note that there is reason for hope. Before the draft guidance was even issued by the FDA in June, several industry sponsors had already partnered with health care professionals to boost clinical trial participation. Read More ›
Chicago, IL—It is well documented that clinical trials thus far have for the most part excluded underserved populations, and that means the results of these trials cannot be generalized to society at large. Fortunately, the federal government and medical societies have taken aim at remedying this imbalance in accrual for clinical trials. Read More ›
Health insurance coverage mediated racial and ethnic inequities among patients with advanced-stage cervical cancer, according to findings from a recent retrospective, cross-sectional, population-based study. Read More ›
Navigating the health insurance landscape in the United States is confusing—and particularly so in light of the ever-changing expansions under the Affordable Care Act (ACA)—but understanding the many existing disparities in cancer-related care and coverage can help providers to offer the best care possible to their patients and to find solutions for those who might be getting left behind. Read More ›
By Liz Beatty
Minority and marginalized communities have historically been underrepresented in local and federal governments and in dozens of private sectors globally. Read More ›